β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer.
Tenbaum SP, Ordóñez-Morán P, Puig I, Chicote I, Arqués O, Landolfi S, Fernández Y, Herance JR, Gispert JD, Mendizabal L, Aguilar S, Ramón y Cajal S, Schwartz S Jr, Vivancos A, Espín E, Rojas S, Baselga J, Tabernero J, Muñoz A, Palmer HG.
Tenbaum SP, et al. Among authors: vivancos a.
Nat Med. 2012 Jun;18(6):892-901. doi: 10.1038/nm.2772.
Nat Med. 2012.
PMID: 22610277
Free article.